| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $28.0M | — | +19.8% |
| SG&A Expense | $6.9M | — | +21.3% |
| Operating Income | -$34.9M | — | -20.1% |
| Pre-tax Income | -$33.7M | — | -22.6% |
| Income Tax | $11K | — | -38.9% |
| Net Income | -$33.7M | — | -22.6% |
| EPS (Basic) | -$0.50 | — | +9.1% |
| EPS (Diluted) | -$0.50 | — | +9.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $84.8M | +42.5% | +121.8% |
| Current Assets | $118.5M | -20.9% | -11.9% |
| Total Assets | $137.7M | -18.7% | -11.4% |
| Current Liabilities | $16.7M | -9.1% | +37.4% |
| Total Liabilities | $30.4M | -6.4% | +10.9% |
| Stockholders' Equity | $107.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$29.9M | — | -28.0% |
| Capital Expenditures | $102K | — | -45.5% |
| Investing Cash Flow | $54.9M | — | +84.1% |
| Financing Cash Flow | $300K | — | +212.5% |
| Free Cash Flow | -$30.0M | — | -27.4% |
| -16.2% |